PT2861241T - Péptidos de cd31 melhorados - Google Patents

Péptidos de cd31 melhorados

Info

Publication number
PT2861241T
PT2861241T PT137297537T PT13729753T PT2861241T PT 2861241 T PT2861241 T PT 2861241T PT 137297537 T PT137297537 T PT 137297537T PT 13729753 T PT13729753 T PT 13729753T PT 2861241 T PT2861241 T PT 2861241T
Authority
PT
Portugal
Prior art keywords
peptides
improved
Prior art date
Application number
PT137297537T
Other languages
English (en)
Original Assignee
Inst Nat Sante Rech Med
Hopitaux Paris Assist Publique
Univ Paris
Univ Paris 13 Paris Nord
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Nat Sante Rech Med, Hopitaux Paris Assist Publique, Univ Paris, Univ Paris 13 Paris Nord filed Critical Inst Nat Sante Rech Med
Publication of PT2861241T publication Critical patent/PT2861241T/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/177Receptors; Cell surface antigens; Cell surface determinants
    • A61K38/1774Immunoglobulin superfamily (e.g. CD2, CD4, CD8, ICAM molecules, B7 molecules, Fc-receptors, MHC-molecules)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/06Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/04Antipruritics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/06Antipsoriatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70596Molecules with a "CD"-designation not provided for elsewhere
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Dermatology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Epidemiology (AREA)
  • Toxicology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Rheumatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Psychiatry (AREA)
PT137297537T 2012-06-19 2013-06-19 Péptidos de cd31 melhorados PT2861241T (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP12305697 2012-06-19
EP13729753.7A EP2861241B1 (en) 2012-06-19 2013-06-19 Improved cd31 peptides
PCT/EP2013/062806 WO2013190014A1 (en) 2012-06-19 2013-06-19 Improved cd31 peptides

Publications (1)

Publication Number Publication Date
PT2861241T true PT2861241T (pt) 2021-07-02

Family

ID=48652100

Family Applications (1)

Application Number Title Priority Date Filing Date
PT137297537T PT2861241T (pt) 2012-06-19 2013-06-19 Péptidos de cd31 melhorados

Country Status (11)

Country Link
US (1) US10815272B2 (pt)
EP (1) EP2861241B1 (pt)
JP (1) JP6357470B2 (pt)
DK (1) DK2861241T3 (pt)
ES (1) ES2877513T3 (pt)
HR (1) HRP20211017T1 (pt)
HU (1) HUE055593T2 (pt)
PL (1) PL2861241T3 (pt)
PT (1) PT2861241T (pt)
SI (1) SI2861241T1 (pt)
WO (1) WO2013190014A1 (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20180125995A (ko) 2016-03-21 2018-11-26 인스티튜트 내셔널 드 라 싼테 에 드 라 리셰르셰 메디칼르 (인 썸) 재관류 손상의 예방 및/또는 치료에서 사용하기 위한 CD31shed 효능제
CN109310788A (zh) * 2016-05-03 2019-02-05 法国国家健康和医学研究院 Cd31shed作为分子靶标用于炎症成像
WO2020109833A1 (en) 2018-11-27 2020-06-04 Institut National De La Sante Et De La Recherche Medicale (Inserm) Method for the modification of a substrate surface by grafting a peptide onto the surface of said substrate
WO2020109836A1 (en) 2018-11-27 2020-06-04 Balt Extrusion Method for the modification of a device surface by grafting a cd31-derived peptide onto the surface of said device
WO2023099932A1 (en) * 2021-12-03 2023-06-08 INSERM (Institut National de la Santé et de la Recherche Médicale) Cd31 mimetic coating for endovascular stent

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6087331A (en) 1990-01-19 2000-07-11 The Blood Center Of Southeastern Wisconsin Therapeutic use of platelet-endothelial cell adhesion molecule-1 compositions
JP3914988B2 (ja) * 2003-08-06 2007-05-16 国立大学法人名古屋大学 細胞死誘導のためのペプチドおよび医薬
EP2313432B1 (en) * 2008-06-30 2017-09-13 Institut National de la Sante et de la Recherche Medicale (INSERM) Use of cd31 peptides in the treatment of thrombotic and autoimmune disorders
EP2836840B1 (en) 2012-04-11 2019-05-08 Institut National de la Sante et de la Recherche Medicale (INSERM) Detection of platelet-derived shed cd31

Also Published As

Publication number Publication date
US20150203536A1 (en) 2015-07-23
JP6357470B2 (ja) 2018-07-11
HRP20211017T1 (hr) 2021-10-01
SI2861241T1 (sl) 2021-11-30
WO2013190014A1 (en) 2013-12-27
DK2861241T3 (da) 2021-07-05
JP2015521611A (ja) 2015-07-30
US10815272B2 (en) 2020-10-27
PL2861241T3 (pl) 2021-10-25
EP2861241A1 (en) 2015-04-22
ES2877513T3 (es) 2021-11-17
EP2861241B1 (en) 2021-04-28
HUE055593T2 (hu) 2021-12-28

Similar Documents

Publication Publication Date Title
IL291571A (en) cx3cr1 binding polypeptides
EP2857033A4 (en) SKIN-PUNKING PEPTIDE
GB201220474D0 (en) Polypeptides
EP2812347A4 (en) AUTOPHAGIA-INDUCING PEPTIDE
GB201218813D0 (en) Antimicrobial peptides
HK1205524A1 (en) Engineered conformationally-stabilized proteins
HK1209138A1 (en) Peptides
PL2861241T3 (pl) Udoskonalone peptydy cd31
HK1203836A1 (en) Bifunctional peptide
GB201218278D0 (en) Translocating peptide
GB201200555D0 (en) Peptide
GB201204868D0 (en) Peptides
GB201220899D0 (en) CD44v6-derived pegylated peptides
GB2500883B (en) Improved saw-horse
GB201223114D0 (en) Novel peptide
HK1201752A1 (en) Alternaria peptides
PT2891663T (pt) Péptidos derivados de psf1
GB201213672D0 (en) Protein
HK1211952A1 (en) Recombinant protein
GB201220328D0 (en) Peptides
GB201211740D0 (en) Peptides
GB201207895D0 (en) Peptides
GB201200509D0 (en) Peptides
HK1202554A1 (en) Cladosporium peptides
GB201221414D0 (en) Trans-locating peptide